Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Soc Nephrol
2016 Feb 01;272:604-14. doi: 10.1681/ASN.2014101025.
Show Gene links
Show Anatomy links
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.
Schlingmann KP
,
Ruminska J
,
Kaufmann M
,
Dursun I
,
Patti M
,
Kranz B
,
Pronicka E
,
Ciara E
,
Akcay T
,
Bulus D
,
Cornelissen EA
,
Gawlik A
,
Sikora P
,
Patzer L
,
Galiano M
,
Boyadzhiev V
,
Dumic M
,
Vivante A
,
Kleta R
,
Dekel B
,
Levtchenko E
,
Bindels RJ
,
Rust S
,
Forster IC
,
Hernando N
,
Jones G
,
Wagner CA
,
Konrad M
.
???displayArticle.abstract???
Idiopathic infantile hypercalcemia (IIH) is characterized by severe hypercalcemia with failure to thrive, vomiting, dehydration, and nephrocalcinosis. Recently, mutations in the vitamin D catabolizing enzyme 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1) were described that lead to increased sensitivity to vitamin D due to accumulation of the active metabolite 1,25-(OH)2D3. In a subgroup of patients who presented in early infancy with renal phosphate wasting and symptomatic hypercalcemia, mutations in CYP24A1 were excluded. Four patients from families with parental consanguinity were subjected to homozygosity mapping that identified a second IIH gene locus on chromosome 5q35 with a maximum logarithm of odds (LOD) score of 6.79. The sequence analysis of the most promising candidate gene, SLC34A1 encoding renal sodium-phosphate cotransporter 2A (NaPi-IIa), revealed autosomal-recessive mutations in the four index cases and in 12 patients with sporadic IIH. Functional studies of mutant NaPi-IIa in Xenopus oocytes and opossum kidney (OK) cells demonstrated disturbed trafficking to the plasma membrane and loss of phosphate transport activity. Analysis of calcium and phosphate metabolism in Slc34a1-knockout mice highlighted the effect of phosphate depletion and fibroblast growth factor-23 suppression on the development of the IIH phenotype. The human and mice data together demonstrate that primary renal phosphate wasting caused by defective NaPi-IIa function induces inappropriate production of 1,25-(OH)2D3 with subsequent symptomatic hypercalcemia. Clinical and laboratory findings persist despite cessation of vitamin D prophylaxis but rapidly respond to phosphate supplementation. Therefore, early differentiation between SLC34A1 (NaPi-IIa) and CYP24A1 (24-hydroxylase) defects appears critical for targeted therapy in patients with IIH.
Abecasis,
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.
2002, Pubmed
Abecasis,
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.
2002,
Pubmed
Antoniucci,
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.
2006,
Pubmed
Beck,
Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.
1998,
Pubmed
Bergwitz,
SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.
2006,
Pubmed
Brodehl,
Postnatal development of tubular phosphate reabsorption.
1982,
Pubmed
Dasgupta,
Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.
2014,
Pubmed
FANCONI,
[Chronic disorders of calcium and phosphate metabolism in children].
1951,
Pubmed
Fenollar-Ferrer,
Structural fold and binding sites of the human Na⁺-phosphate cotransporter NaPi-II.
2014,
Pubmed
Halbritter,
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
2015,
Pubmed
Kato,
Molecular genetics of vitamin D- dependent hereditary rickets.
2002,
Pubmed
Kaufmann,
Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD.
2014,
Pubmed
Kenny,
Sotos syndrome, infantile hypercalcemia, and nephrocalcinosis: a contiguous gene syndrome.
2011,
Pubmed
Lameris,
Involvement of claudin 3 and claudin 4 in idiopathic infantile hypercalcaemia: a novel hypothesis?
2010,
Pubmed
Lapointe,
NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak.
2006,
Pubmed
,
Xenbase
LIGHTWOOD,
Idiopathic hypercalcaemia in infants.
1953,
Pubmed
Lorenz-Depiereux,
Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.
2006,
Pubmed
Magen,
A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome.
2010,
Pubmed
,
Xenbase
Nesterova,
1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.
2013,
Pubmed
Nowik,
Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption.
2008,
Pubmed
Patti,
Conferring electrogenicity to the electroneutral phosphate cotransporter NaPi-IIc (SLC34A3) reveals an internal cation release step.
2013,
Pubmed
,
Xenbase
Perwad,
Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice.
2005,
Pubmed
Pfister,
Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters.
1997,
Pubmed
Prié,
Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.
2002,
Pubmed
,
Xenbase
Rajagopal,
Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis.
2014,
Pubmed
Reshkin,
Functional asymmetry of phosphate transport and its regulation in opossum kidney cells: phosphate transport.
1990,
Pubmed
Schlingmann,
Mutations in CYP24A1 and idiopathic infantile hypercalcemia.
2011,
Pubmed
Segawa,
Type IIc sodium-dependent phosphate transporter regulates calcium metabolism.
2009,
Pubmed
Stark,
Direct measurement of TP/GFR: a simple and reliable parameter of renal phosphate handling.
1986,
Pubmed
Tenenhouse,
Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter.
2005,
Pubmed
Tenenhouse,
1alpha-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene.
2004,
Pubmed
Tieder,
Elevated serum 1,25-dihydroxyvitamin D concentrations in siblings with primary Fanconi's syndrome.
1988,
Pubmed
Virkki,
Functionally important residues in the predicted 3(rd) transmembrane domain of the type IIa sodium-phosphate co-transporter (NaPi-IIa).
2005,
Pubmed
,
Xenbase
Virkki,
Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa.
2003,
Pubmed
,
Xenbase
Wagner,
The SLC34 family of sodium-dependent phosphate transporters.
2014,
Pubmed
Yu,
Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.
2012,
Pubmed
